EGFR and brain neoplasm: All primary brain tumors harbored at least one oncogenic mutation and consistent with the genomic profiles observed in TCGA cohort, TP53 (52%), NF1 (34%), ATRX (32%), IDH1 (24%), PIK3CA (14%), EGFR (20%), and BRAF (8%) were frequently mutated.